Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

RNASARC - Molecular Screening Program of Soft Tissue Sarcomas With Complex Genomic Profile to Detect NTRK1/2/3, ROS1 or ALK Gene Fusions.

NCT03375437 is registered in ClinicalTrials.gov with Centre Leon Berard as lead sponsor.

NCT NCT03375437
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT03375437 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
RNASARC - Molecular Screening Program of Soft Tissue Sarcomas With Complex Genomic Profile to Detect NTRK1/2/3, ROS1 or ALK Gene Fusions.
Lead sponsor
Centre Leon Berard
Phase
Not applicable
Overall status
Active, not recruiting
Start date
February 15, 2018
Completion date
December 15, 2025
Enrollment
376 (actual)
Sites
10

Conditions

As the registry lists them; a condition with its own page is linked.

advanced cancer, metastatic cancer, soft tissue sarcoma